AptarGroup Inc (ATR) Actualités

Form 8-K - Current report

Aptar Reports Fourth Quarter and Annual 2024 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that...

Aptar Named One of America’s Most Responsible Companies by Newsweek for the Sixth Consecutive Year

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Aptar Announces 2025 Quarterly Conference Call Dates

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the...

Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced their...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities